Daubert Hearings for Zantac Cancer Lawsuits To Be Held in September 2022
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
Canadian health regulators have announced an Accuretic recall, indicating the Pfizer hypertension drug contains levels of cancer-causing chemicals above the acceptable amounts.
A federal judge is calling on parties in Zantac cancer litigation to finalize a registry of potential plaintiffs and their information as the lawsuits enter the latter stages of pretrial…
Plaintiffs have identified five types of cancer which will be pursued in federal Zantac lawsuits, including bladder cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer.
Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.
Parties involved in litigation over the cancer risks of the heartburn drug Zantac will take part in a Zantac Science Day today and tomorrow in federal court.
A pool of 200 randomly selected Zantac cancer claims will form the initial discovery pool, from which the first bellwether cases will be selected.
A federal judge has called for a "Science Day" to help explain to the Court the scientific concepts behind Zantac, NDMA and the alleged health risks which led to the…
Parties involved in Zantac cancer litigation will meet next week to discuss plans for selecting potential bellwether test cases to go before juries.
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.